中药制剂介入治疗恶性肿瘤39例临床疗效分析

目的:探讨中药制剂介入治疗恶性肿瘤的临床疗效、生活质量改善情况及不良反应发生情况,为临床诊断治疗提供依据。方法:选择2007年5月～2013年6月期间在我院接受诊治的78例恶性肿瘤患者,按随机数字表法将78患者随机分为对照组与治疗组各39例。对照组仅给予化疗方案治疗,治疗组在对照组基础上给予中药制剂介入治疗。结果:治疗组总有效率(56.41%)显著高于对照组(33.33%),有显著性差异(P<0.05);治疗组生活质量改善率(46.15%)显著高于对照组(23.08%),有显著性差异(P<0.05);治疗组不良反应率(23.08%)显著低于对照组(48.72%),有显著性差异(P<0.05)。结论:中药制剂介入治疗恶性肿瘤患者疗效显著,可显著提高患者生活质量,且不良反应较少,临床上应用具有重要价值,值得推广。

Clinical Analysis on 39 Cases of Malignant Tumor Treated by Interventional Treatment with Traditional Chinese Medicine

Objective： To observe and study the clinical effect of traditional chinese medicine in the treatment of malignant tumor on patients＇ recovering health condition and adverse reactions, in order to provide the basis for clinical diagnosis of similar treatment. Method： From May 2007 to June 2013, 78 hospitalized patients with malignant tumor in our hospital were randomly divided into control group and treatment group, each group with 39 patients. The control group were applied to chemotherapy, while the treatment group were given chinese medicine plus conventional chemotherapy. Results： the total effective rate of the treatment group （56.41%） was significantly higher than that of the control group （33.33%）; likewise, the rate of recovering health condition in the treatment group （46.15%） was significantly higher than that of the control group （23.08%）, and the total adverse reaction rate in the treatment group （23.08%） was significantly lower than that of the control group （48.72%）. Statistically, all three pairs of indexes showed significant differences （P〈0.05）. Conclusion： Interventional treatment with traditional chinese medicine helps patients with malignant tumor improve health condition and lowers adverse reaction rates, therefore should be adopted in wider clinical treatment.